Distinct genetic architecture of coronary heart disease in dyslipidemia patients
Abstract Background Mutations of LDLR, APOB and PCSK9 have been well-established to cause hypercholesterolemia while the pathogenic effects of LPL has been confirmed by cohorts and functional studies in hypertriglyceridemia. However, these mutations do not fully account for all dyslipidemia, and it...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2026-05-01
|
| סדרה: | BMC Medical Genomics |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12920-026-02388-5 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
